ArticleBMJ open2022

Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2).

Konstantinos Liatsikos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.